These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26637184)

  • 1. Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
    Nijland PG; Molenaar RJ; van der Pol SM; van der Valk P; van Noorden CJ; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2015 Dec; 3():79. PubMed ID: 26637184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
    Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hypoxia in development selectively alters the activities of key enzymes of glucose oxidative metabolism in brain regions.
    Lai JC; White BK; Buerstatte CR; Haddad GG; Novotny EJ; Behar KL
    Neurochem Res; 2003 Jun; 28(6):933-40. PubMed ID: 12718448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
    Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
    Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
    Nijland PG; Witte ME; van het Hof B; van der Pol S; Bauer J; Lassmann H; van der Valk P; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2014 Dec; 2():170. PubMed ID: 25492529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.
    Magistretti PJ; Pellerin L
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1155-63. PubMed ID: 10466143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial changes within axons in multiple sclerosis.
    Mahad DJ; Ziabreva I; Campbell G; Lax N; White K; Hanson PS; Lassmann H; Turnbull DM
    Brain; 2009 May; 132(Pt 5):1161-74. PubMed ID: 19293237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.
    Mizee MR; Nijland PG; van der Pol SM; Drexhage JA; van Het Hof B; Mebius R; van der Valk P; van Horssen J; Reijerkerk A; de Vries HE
    Acta Neuropathol; 2014 Nov; 128(5):691-703. PubMed ID: 25149081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
    Zeis T; Howell OW; Reynolds R; Schaeren-Wiemers N
    Exp Neurol; 2018 Jul; 305():76-88. PubMed ID: 29596844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate source influences gelatinase production by mouse astrocytes in vitro.
    Massengale JL; Gasche Y; Chan PH
    Glia; 2002 May; 38(3):240-5. PubMed ID: 11968061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions.
    Kipp M; Gingele S; Pott F; Clarner T; van der Valk P; Denecke B; Gan L; Siffrin V; Zipp F; Dreher W; Baumgartner W; Pfeifenbring S; Godbout R; Amor S; Beyer C
    Brain Behav Immun; 2011 Nov; 25(8):1554-68. PubMed ID: 21620951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of distinct galectins in multiple sclerosis lesions.
    Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
    van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
    Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis.
    Trapp BD; Stys PK
    Lancet Neurol; 2009 Mar; 8(3):280-91. PubMed ID: 19233038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
    Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
    Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
    Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.